Industry
Robot-Assisted PCR Among Innovations Driving qPCR Sector
Seeking efficiency in the qPCR process, a number of automation and robotics technologies have been added to product offerings from top competitors. According to the new Kalorama Information report “qPCR and dPCR Markets: Clinical and Research Markets,” this is one factor driving the usefulness of this workhorse lab technology. More...21 Dec 2014
Roche Acquires High-Precision Dissection Technology from AvanSci Bio
Roche Diagnostics of the Roche group has signed a definitive Asset Purchase Agreement with AvanSci Bio for all products associated with the high-performance microdissection of slide-mounted tissue sections for subsequent molecular analysis. More...15 Dec 2014
Roche Enters Additional Sectors with Acquisition of Ariosa
Healthcare biotech leader Roche has announced its acquisition of privately held Ariosa Diagnostics, a leading molecular diagnostics testing service provider of a highly targeted and accurate noninvasive prenatal testing service through their CLIA laboratory using cell-free DNA technology. More...09 Dec 2014
Foundations Fund Fast-Track Development of Ebola Test
Cepheid, a leading molecular diagnostics company, has announced the award of a grant of up to USD 3.3 million co-financed by the Paul G. Allen Family Foundation and the Bill & Melinda Gates Foundation to quickly develop its “Xpert Ebola” test for use in regions worst hit by the epidemic. Cepheid expects to deliver a prototype in as little as eight weeks. More...07 Dec 2014
Gold Member
Veterinary Hematology Analyzer
Exigo H400
New
Silver Member
Autoimmune Hepatitis Test
LKM-1-Ab ELISA
New
Modular Hemostasis Automation Solution
CN Track
In Other News
Women’s Health Diagnostics Grows to USD 8 Billion Sector
Oncology Companion Diagnostics Sector Grows to Over USD 1 Billion
Collaboration to Bring Personalized Cancer Care to Singapore
Market for qPCR Exceeds USD 3 Billion
Eurofins Genomics Buys VBC-Biotech Businesses, Establishes Austrian Subsidiary
Aperiomics Launches Novel NGS Services
Distribution Agreement Will Streamline Methotrexate Determinations
Blood Sector Continues to Experience Solid Growth
Partners to Develop Rapid Ebola Point-of-Care Test
Tumor BRAC Analysis CDx Lab Established in Europe
Ventana to Develop Companion Diagnostics for ImmunoGen Anticancer Agents
ERBA Diagnostics Enters Brazilian Sector with Leading-Edge Clinical Testing Portfolio
French-German Cooperation to Improve Personalized Cancer Care
BD Advances Entry into NGS with Acquisition of GenCell Biosystems
GlaxoSmithKline Boosts Global Cancer Testing With GE Healthcare Deal
Emergency Approval of Ebola Test Suggests Opportunity for Test Makers
EKF and Mass. General Collaborate to Develop Blood Tests for Cancer Patients
Merck KGaA to Buy Sigma-Aldrich for USD 17 Billion
Initiative Launched to Make Genetic Profiles a Routine Part of Clinical Decisions
Funding Awarded to Develop Diagnostic Point-of-Care Device for Sickle Cell Disease
First European Company Obtains CE-IVD Marking for Next Generation Sequencing in Routine Testing
Physician Office IVD Sector Nears USD 2.5 Billion
Newly CE-Marked Automated Respiratory Disease Assay Now Available
LabMedica Industry News channel reports on mergers and takeovers, on cooperative agreements and on trends in the IVD industry worldwide.
